መነሻBIOGY • OTCMKTS
add
Biogaia Adr Class B
የቀዳሚ መዝጊያ
$10.00
የዓመት ክልል
$9.72 - $12.09
የገበያው አጠቃላይ ዋጋ
11.73 ቢ SEK
አማካይ መጠን
150.00
የገበያ ዜና
ፋይናንስ
የገቢ መግለጫ
ገቢ
የተጣራ ገቢ
| (SEK) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ገቢ | 303.97 ሚ | -4.32% |
የሥራ ወጪ | 124.96 ሚ | 7.14% |
የተጣራ ገቢ | 36.60 ሚ | -63.94% |
የተጣራ የትርፍ ክልል | 12.04 | -62.32% |
ገቢ በሼር | — | — |
EBITDA | 103.72 ሚ | -16.66% |
ውጤታማ የግብር ተመን | 22.09% | — |
ቀሪ ሒሳብ ሉሆች
አጠቃላይ ንብረቶች
አጠቃላይ ተጠያቂነቶች
| (SEK) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
ጥሬ ገንዘብና የአጭር ጊዜ መዋዕለ ንዋይ | 1.11 ቢ | -23.26% |
አጠቃላይ ንብረቶች | 1.90 ቢ | -17.33% |
አጠቃላይ ተጠያቂነቶች | 285.12 ሚ | -10.62% |
አጠቃላይ እሴት | 1.62 ቢ | — |
የሼሮቹ ብዛት | 101.16 ሚ | — |
የገበያ ዋጋ እና የተገለጸ ዋጋ | 0.62 | — |
የእሴቶች ተመላሽ | 12.79% | — |
የካፒታል ተመላሽ | 15.24% | — |
የገንዘብ ፍሰት
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ
| (SEK) | ሴፕቴ 2024info | ከዓመት ዓመት ለውጥ |
|---|---|---|
የተጣራ ገቢ | 36.60 ሚ | -63.94% |
ከክወናዎች የተገኘ ጥሬ ገንዘብ | 100.03 ሚ | 1.06% |
ገንዘብ ከኢንቨስትመንት | -2.81 ሚ | 68.53% |
ገንዘብ ከፋይናንስ | 14.23 ሚ | 939.29% |
የተጣራ ዝርዝር ገንዘብ በጥሬ ገንዘብ | 106.86 ሚ | 28.81% |
ነፃ የገንዘብ ፍሰት | 74.41 ሚ | 104.18% |
ስለ
BioGaia is a Swedish biotechnology company that develops, markets and sells a range of probiotic products. It has patented the use of several Lactobacillus reuteri strains and offers gut and immune health products containing L. reuteri Protectis. Their oral health products contain L. reuteri Prodentis, a blend of the L. reuteri strains DSM 17938 and ATCC PTA 5289. Products containing L. reuteri have been proven to be both effective and safe in several applications: infant colic, diarrhea prevention and mitigation in children, eradication of H. pylori infection and reduction of side effects from standard H. pylori treatment, amelioration of gingivitis, and general illness prevention in children and adults. BioGaia was ranked 9th in the Top 30 Global Probiotic Food Ingredient Companies list by FoodTalks in 2021. The BioGaia -B share is listed on the NASDAQ OMX Nordic Exchange. Wikipedia
ዋና ሥራ አስፈጻሚ
የተመሰረተው
1990
ድህረገፅ
ሠራተኞች
222
